This week in Other Barks & Bites: the Ninth Circuit holds that public policy arguments cannot overturn claims to monetary damages stemming from a French copyright proceeding; the Ninth Circuit also affirmed that the discovery rule still applies to copyright claims despite the application of laches to the Copyright Act’s statute of limitations in Petrella v. Metro-Goldwyn-Mayer; Judge Newman dissents from the Federal Circuit’s ruling that an error in asserted prior art is merely typographical and would have been overlooked by a person of ordinary skill in the art; WIPO Director Tam calls on attendees of the WIPO Assemblies to use IP as a “powerful catalyst for jobs”; TSMC posts record quarterly net income as the company provides optimistic guidance on supply chain issues in the chip market; and the CJEU rules that “Feta”-branded cheese sold by Danish cheese makers violates EU law on protected designations of origin even when that cheese is sold outside of the EU.
Patent
- Enablement
- Fee Shifting
- Litigation
- Other Barks & Bites for Friday, March 31: Japan Restricts Chip-Making Exports, Ocado Scores UK High Court Win in Robotic Warehousing Case, and Judge Rejects Fair Use Defense for Internet Archive
- U.S. Government Sides with Teva in Skinny Label SCOTUS Fight
- Industry, NGOs Spar Over Need to Extend TRIPS COVID IP Waiver at ITC Hearing
- Software-Related U.S. Patent Grants in 2022 Remained Steady While Chinese Software Patents Rose 8%
- The Truth Leaks Out: Justices Struggle with the Science, Sanofi Welcomes End to Functional Genus Claims in Amgen Oral Arguments
Recent Posts
- Other Barks & Bites for Friday, March 31: Japan Restricts Chip-Making Exports, Ocado Scores UK High Court Win in Robotic Warehousing Case, and Judge Rejects Fair Use Defense for Internet Archive
- U.S. Government Sides with Teva in Skinny Label SCOTUS Fight
- Industry, NGOs Spar Over Need to Extend TRIPS COVID IP Waiver at ITC Hearing
- Software-Related U.S. Patent Grants in 2022 Remained Steady While Chinese Software Patents Rose 8%
- The Truth Leaks Out: Justices Struggle with the Science, Sanofi Welcomes End to Functional Genus Claims in Amgen Oral Arguments